Overview
Aloe describes a genus including over 500 species of flowering succulent plants that grow in the Southern peninsula and various islands. Aloe vera, or Aloe barbadensis miller, is the most common species of Aloe that is cultivated for agricultural and medical purposes. It is a perennial succulent xerophyte with elongated leaves that contain a clear gel. While aloe vera has a long history of commercial uses, it is still widely used in cosmetic, food and pharmaceutical products. The use of aloe vera in constipation, inflammatory disorders, cancer, ulcer, and diabetes has also been investigated . The active constituents of aloe vera include polysaccharides with protective effects on skin, as they exhibit antioxidant and anti-inflammatory properties . Common active polysaccharides include glucomannans, polymannose, and acemannan, or b-(1–4)-acetylated polymannose . Acemannan and other modified polysaccharides are responsible in preventing suppression of contact hypersensitivity or immune suppression induced by external factors such as irradiation .
Indication
Indicated for use as a topical agent to soothe sensitive skin and to relieve symptoms of various skin conditions, including contact or atopic dermatitis, eczema, dermatitis and acne urticata, first- and second-degree burns, radiation dermatitis, and sunburn.
Associated Conditions
- Acne
- Atopic Dermatitis
- Contact dermatitis and other eczema
- Dermatosis
- Folliculitis
- Intertrigo
- Lichen simplex chronicus
- Moniliasis
- Nummular Dermatitis
- Pruritus Ani
- Pyoderma
- Stasis dermatitis
- Disseminated Neurodermatitis
- Genital pruritus
- Localized Neurodermatitis
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2025/03/17 | Phase 4 | Completed | |||
2025/03/06 | Phase 1 | Completed | Minia University | ||
2024/02/06 | Not Applicable | Completed | Islamabad Medical and Dental College | ||
2023/09/18 | Phase 4 | Completed | |||
2021/02/15 | Not Applicable | Completed | Ospedale Sandro Pertini, Roma | ||
2020/12/10 | Phase 2 | Completed | Zainab J Abbas | ||
2019/07/05 | Not Applicable | Completed | |||
2017/06/29 | Phase 2 | Completed | Government Dental College and Research Institute, Bangalore | ||
2017/04/11 | Phase 2 | UNKNOWN | |||
2016/06/30 | Phase 1 | Withdrawn |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
Newton Laboratories, Inc. | 55714-2596 | ORAL | 15 [hp_X] in 1 mL | 5/21/2025 | |
Newton Laboratories, Inc. | 55714-4862 | ORAL | 15 [hp_X] in 1 mL | 5/21/2025 | |
Primus Pharmaceuticals | 68040-706 | TOPICAL | 10 mg in 1 g | 10/7/2009 | |
Primus Pharmaceuticals | 68040-705 | TOPICAL | 10 mg in 1 g | 10/30/2009 | |
Syntenza Pharmaceuticals LLC | 72056-020 | TOPICAL | 10 mg in 1 g | 5/6/2020 | |
Guangzhou Yapeng Refinement Chemical Co., Ltd. | 84356-007 | TOPICAL | 13 g in 100 g | 6/20/2025 | |
Deseret Biologicals, Inc. | 43742-2276 | ORAL | 8 [hp_X] in 1 mL | 5/7/2025 | |
Newton Laboratories, Inc. | 55714-4838 | ORAL | 15 [hp_X] in 1 mL | 5/21/2025 | |
Shanghai Tongjie Commodity Co.,Ltd. | 85511-001 | TOPICAL | 10 mg in 100 mg | 4/9/2025 | |
King Bio Inc. | 57955-1814 | ORAL | 12 [hp_X] in 236 mL | 5/20/2025 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
SANKAIJO TABLET | SIN03486P | TABLET, FILM COATED | 12.5 mg | 6/24/1989 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
NutriVital Premium Gut Support Complex | 326954 | Medicine | A | 12/2/2019 | |
Overnight Cleanse | 344734 | Medicine | A | 9/28/2020 | |
Gut Calm + Restore | 444372 | Medicine | A | 3/25/2024 | |
YHL PREMIUM SHEEP PLACENTA 50000 | 353749 | Medicine | A | 1/28/2021 | |
ATHELITE LAVA JOINT & MUSCLE PAIN RELIEF CREAM | 429411 | Medicine | A | 12/1/2023 | |
Athelite Infinity Queen Women’s Pain Relief Spray | 412170 | Medicine | A | 7/3/2023 | |
Arborvitae ModeX | 407405 | Medicine | A | 4/6/2023 | |
Phys10 Ultra Armour Joint and Muscle Pain Relief Spray | 484428 | Medicine | A | 3/27/2025 | |
Biogenic Aloe Vera Juice | 80030 | Medicine | A | 8/23/2001 | |
Bioeffective (R) Gel | 168983 | Medicine | A | 2/11/2010 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
HOMEOPATHIC MEDICINE (S NO. 249) DPS 30C | total health centre | 02077043 | Drops - Oral | 30 C / ML | 12/31/1994 |
UNDA 46 | seroyal international inc. | 02233262 | Liquid
,
Drops
,
Granules
,
Pellet
,
Tablet - Oral | 10 X | 4/6/1998 |
SEPIA COMPOSE DPS | laboratoires holis inc. | 01934422 | Drops - Oral | 3 CH / DH | 12/31/1984 |
ALOE SOCOTRINA GRANULE 1DH-30DH | homeocan inc. | 00855545 | Tablet - Oral | 1 DH | 12/31/1991 |
ALOE | seroyal international inc. | 02233083 | Drops
,
Tablet
,
Liquid
,
Pellet
,
Granules
,
Globules - Oral | 1 X | 4/6/1998 |
ALOE GOUTTE 4CH-30CH | dolisos laboratoires s.a. | 00680486 | Drops - Oral | 2 CH / CH | 12/31/1987 |
ONE TIME COMPOUND BENZOIN TCT F466 | ACME UNITED CORPORATION | 00518301 | Stick - Topical | 2 % | 12/31/1979 |
HP5 TAB | 01975870 | Tablet - Oral | 3 X | 10/4/1996 | |
ALSIDOZ TAB | alsi cie ltee | 00393665 | Tablet - Oral | 16.25 MG | 12/31/1977 |
ALOE GRANULE 1DH - 30CH | dolisos laboratoires s.a. | 00698962 | Tablet - Oral | 1 DH / DH | 12/31/1987 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.